Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study

Authors:

Abstract
We investigated associations of plasma lipoproteins with subclinical interstitial lung disease (ILD) by measuring high attenuation areas (HAA: lung voxels between −600 and −250 Hounsfield units) in 6700 adults and serum MMP-7 and SP-A in 1216 adults age 45–84 without clinical cardiovascular disease in Multi-Ethnic Study of Atherosclerosis. In cross-sectional analyses, each SD decrement in high density lipoprotein cholesterol (HDL-C) was associated with a 2.12% HAA increment (95% CI 1.44% to 2.79%), a 3.53% MMP-7 increment (95% CI 0.93% to 6.07%) and a 6.37% SP-A increment (95% CI 1.35% to 11.13%), independent of demographics, smoking and inflammatory biomarkers. These findings support a novel hypothesis that HDL-C might influence subclinical lung injury and extracellular matrix remodelling.
Funding Information
  • National Heart, Lung, and Blood Institute (HHSN268201500003I, K24-HL-131937, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, R01-93081, R01-HL-077612, R01-HL103676, RC1-100543, T32-H-105323)
  • Pulmonary Fibrosis Foundation
  • National Center for Research Resources (UL1-TR-000040, UL1-TR-001079)

This publication has 20 references indexed in Scilit: